Valentis Life Sciences Limited 10505028 science products true 1 April 2023 10505028 2023-04-01 2024-03-31 10505028 2023-03-31 10505028 2024-03-31 10505028 2022-04-01 2023-03-31 10505028 2022-03-31 10505028 2023-03-31 10505028 frs102-bus:FRS102 2023-04-01 2024-03-31 10505028 frs102-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10505028 frs102-bus:FullAccounts 2023-04-01 2024-03-31 10505028 frs102-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 10505028 frs102-bus:EntityNoLongerTradingButTradedInPast 2023-04-01 2024-03-31 10505028 frs102-core:CurrentFinancialInstruments 2024-03-31 10505028 frs102-core:CurrentFinancialInstruments 2023-03-31 10505028 frs102-core:Non-currentFinancialInstruments 2024-03-31 10505028 frs102-core:Non-currentFinancialInstruments 2023-03-31 10505028 frs102-core:ShareCapital 2024-03-31 10505028 frs102-core:ShareCapital 2023-03-31 10505028 frs102-core:RetainedEarningsAccumulatedLosses 2024-03-31 10505028 frs102-core:RetainedEarningsAccumulatedLosses 2023-03-31 10505028 frs102-bus:Director1 2023-04-01 2024-03-31 10505028 frs102-bus:OrdinaryShareClass1 2024-03-31 10505028 frs102-bus:OrdinaryShareClass1 2023-03-31 10505028 frs102-bus:OrdinaryShareClass1 2023-04-01 2024-03-31 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares
Registered number
10505028
Valentis Life Sciences Limited
Unaudited Accounts
for the year ended
31 March 2024
Valentis Life Sciences Limited
Balance Sheet
as at 31 March 2024
Notes
2024
£
2023
£
Current assets
Debtors 3 3,251 3,251
Cash at bank and in hand 1,520 1,520
4,771 4,771
Creditors: amounts falling due within one year 4 (94,633) (94,633)
Net current assets / (liabilities) (89,862) (89,862)
Total assets less current liabilities (89,862) (89,862)
Creditors: amounts falling due after more than one year 5 (11,083) (11,083)
Provisions for liabilities (0) (0)
Total net assets (liabilities) (100,945) (100,945)
Capital and reserves
Called up share capital 6 400 400
Profit and loss account (101,345) (101,345)
Shareholders' funds (100,945) (100,945)

Valentis Life Sciences Limited
Balance Sheet
as at 31 March 2024



These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 31 March 2024 the company was entitled to exemption as a dormant company under section 480 of the Companies Act 2006.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr R Sharma

Director


Approved by the board on 30 August 2024

Company Number: 10505028 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

10505028 - Companies House Default Address
Cardiff
CF14 8LH

Valentis Life Sciences Limited
Notes to the Accounts
for the year ended 31 March 2024

1. Accounting policies

Basis of preparation of financial statements
These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.
Going concern basis
The accounts have not been prepared on the assumption that the company is able to carry on business as a going concern for the foreseeable future. The company has ceased trading.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares that are measured at fair value. Derivative financial instruments are initially recorded at cost and thereafter at fair value. All changes in fair value are recognised in the profit or loss account in the period in which they occurred.
2. Employees
2024 2023
Average number of employees during the period 0 0

3. Debtors
2024 2023
£ £
Other debtors 3,251 3,251
3,251 3,251

4. Creditors: amounts falling due within one year
2024 2023
£ £
Bank Loans & Overdrafts 3,500 3,500
Taxation & social security 3,158 3,158
Other creditors 87,975 87,975
94,633 94,633

5. Creditors: amounts falling due after one year
2024 2023
£ £
Bank Loans & overdrafts 11,083 11,083
11,083 11,083

6. Share capital
2024 2023
£ £
Allotted, called up and fully paid:
400 (2023: 400) Ordinary shares of £1.00 each 400 400
400 400